Well Done, LLC Rani Therapeutics Holdings, Inc. Call Options Transaction History
Well Done, LLC
- $521 Million
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding RANI
# of Institutions
44Shares Held
6.26MCall Options Held
29.4KPut Options Held
0-
Armistice Capital, LLC New York, NY3.15MShares$1.58 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA800KShares$399,8390.0% of portfolio
-
Nan Fung Group Holdings LTD Central, K3494KShares$246,7920.48% of portfolio
-
United Services Automobile Association San Antonio, TX303KShares$151,3710.02% of portfolio
-
Geode Capital Management, LLC Boston, MA191KShares$95,2780.0% of portfolio
About Rani Therapeutics Holdings, Inc.
- Ticker RANI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,492,000
- Market Cap $12.2M
- Description
- Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company that develops orally administered biologics. The company develops the RaniPill capsule, a platform that is intended to replace subcutaneous or IV injection of biologics with oral dosing. Its product pipeline includes RT-101, an octreotide, which has completed P...